Metoprolol Succinate | Excipients | Inactive | Generic | Formulation | PharmaCompass.com

Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Metoprolol Succinate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

59 API Suppliers, 35 USDMF, 16 CEP/COS, 17 EU WC, 19 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

286 FDF Dossiers, 99 FDA Orange Book, 120 Europe, 27 Australia, 40 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 3 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 30 BASF, 1 CD Formulation, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 2 Gloria Interchem, 12 Ideal Cures, 3 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 2 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

66 Coating Systems & Additives, 61 Fillers, Diluents & Binders, 39 Solubilizers, 39 Controlled & Modified Release, 35 Thickeners and Stabilizers, 32 Disintegrants & Superdisintegrants, 30 Granulation, 30 Direct Compression, 23 Lubricants & Glidants, 22 Film Formers & Plasticizers, 19 Topical, 15 Taste Masking, 13 Parenteral, 12 Chewable & Orodispersible Aids, 11 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 7 Rheology Modifiers, 6 Surfactant & Foaming Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

34 News #PharmaBuzz

34 News #PharmaBuzz

GLOBAL SALES INFORMATION

27 US Medicaid Prescriptions, 8 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents

8 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP

$ Xls

Filters

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.